Neuronetics Inc

Healthcare · Medical Devices

2.80$ -2.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Neuronetics Inc (STIM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 132 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet STIM
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	25	–	–	–	39	32	28	119	117	113	109	105	100	88	80	78	79	152	148	143	141	130	123	119	117	104	100	93	116	104	97	74	141	142	135	145	142	125	132
Current Assets	23	17	–	–	37	30	26	117	114	106	101	96	88	76	67	65	65	139	135	119	115	103	95	101	99	81	78	71	94	82	76	53	58	61	56	65	62	47	53
Cash	17	-17	–	–	29	20	15	107	105	96	90	82	76	64	54	51	49	121	116	99	94	81	71	74	70	55	46	36	60	48	43	21	19	21	17	34	34	13	19
Cash & Short-Term Investments	–	17	–	–	29	20	15	107	105	96	90	82	77	64	54	51	51	123	118	102	96	83	73	76	72	57	47	37	61	49	43	21	20	21	18	35	34	13	19
Receivables	3.6	–	–	–	4.3	4.3	4.7	5.3	5.6	5.8	7.8	8.2	6.6	7.4	7.9	7.2	7.2	7.0	9.0	7.7	7.8	8.3	11	12	14	11	15	17	18	20	20	19	24	27	27	19	17	16	16
Inventory	1.7	–	–	–	2.5	2.6	2.4	2.6	2.4	2.4	2.6	2.9	2.8	2.9	3.3	3.8	3.7	5.4	5.4	5.4	6.6	7.6	7.2	8.6	8.9	9.1	8.9	9.7	8.1	6.7	6.1	5.0	4.2	4.1	4.9	4.3	4.3	4.7	5.5
Property, Plant & Equipment	1.6	–	–	–	1.4	1.4	1.5	1.3	1.4	5.3	5.1	4.9	4.9	4.7	4.4	0.8	0.7	0.9	3.9	0.9	5.1	5.6	5.7	5.6	2.0	2.0	2.1	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	–	–	–	19	19	19	23	24	24	24
Intangible Assets	–	–	–	–	0.4	–	0.0	0.7	1.0	1.2	1.1	0.9	1.2	1.3	1.3	1.3	1.2	1.4	–	–	2.5	–	–	–	3.6	–	–	–	4.2	–	–	–	20	19	19	19	18	18	17
Total Liabilities	30	–	–	–	232	42	234	43	46	48	50	51	52	52	51	51	53	50	51	52	56	53	55	56	60	55	55	55	82	76	77	65	109	102	103	114	115	108	110
Current Liabilities	13	–	–	–	12	10	15	15	14	12	17	22	28	12	45	46	14	11	12	48	16	13	19	25	33	15	15	15	20	14	29	17	31	25	28	29	31	28	28
Short-Term Debt	4.5	20	–	–	30	30	2.5	5.0	–	0.5	4.8	8.6	12	0.6	35	35	0.6	0.6	0.6	36	0.7	0.7	5.2	9.6	14	0.8	0.8	0.8	0.8	0.9	14	0.9	4.8	4.9	5.3	5.6	5.6	5.4	5.1
Accounts Payable	1.5	–	–	–	2.5	3.0	2.9	2.1	3.8	2.6	3.7	4.1	4.6	3.6	2.3	2.4	3.7	3.2	2.4	3.3	4.3	2.8	2.4	2.4	2.4	5.0	4.1	2.8	4.8	3.0	4.1	3.3	11	8.5	9.7	12	11	11	12
Long-Term Debt	16	–	–	–	30	30	27	25	30	31	27	23	20	34	–	–	35	35	35	–	35	35	31	27	23	37	37	37	59	59	46	46	55	55	56	66	66	61	62
Shareholders' Equity	-177	-4.4	–	–	-193	-10	-205	76	71	65	60	54	48	37	29	27	25	102	97	91	85	77	68	63	57	48	45	38	34	28	19	9.4	28	35	27	27	22	13	18
Retained Earnings	-181	–	–	–	-197	-202	-210	-215	-221	-229	-236	-243	-250	-263	-270	-274	-278	-285	-293	-301	-309	-320	-330	-338	-346	-356	-361	-371	-376	-384	-394	-407	-420	-432	-443	-452	-459	-470	-473
Shares Outstanding	–	0.0	0.0	0.0	0.0	17	17	17	18	18	18	19	19	19	19	19	19	25	26	26	26	27	27	27	27	28	29	29	29	29	30	30	37	61	66	67	69	70	71

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings